Enabling early diagnosis and efficient management of neurodegenerative diseases
Healthcare professionals are often overwhelmed with data, making the interpretation challenging in clinical decision making.
cNeuro® from Combinostics gives healthcare professionals a comprehensive view of patient data which helps them to make an early diagnosis of neurodegenerative diseases.
While there are no effective treatments for neurodegenerative diseases like Alzheimer’s, early-stage diagnosis combined with symptomatic treatment and lifestyle intervention can make a drastic difference to quality of life in later years.
cNeuro® is Combinostics’ cloud platform for quantitative assessment of brain images and for providing clinical decision support in neurological disorders.
cNeuro® has two product modules, cMRI and cDSI.
Quantify volumes of 133 brain regions, vascular burden and in the EU, compute medial temporal lobe atrophy (MTA) score, global cortical atrophy (GCA) scale and Fazekas scale.
Compare measures to reference data.
Review results interactively in a web viewer using a standard web browser and obtain a report.
Compare neuropsychology, MRI, CSF and genetics measured from your patient to data of previously diagnosed cases.
Quantify the patient’s similarity relative to etiology (AD, FTLD, VaD and cognitive normal) and progression (stable and progressive MCI).
Visualize data in an intuitive way with our patented disease state fingerprint (DSI) technology.
Combinostics will be attending the RSNA 2020 virtual exhibition from the 29th of November to the 5th of December. To find out more, come and talk to us at our virtual booth via the following link:...
The COVID-19 pandemic has highlighted the need for remote testing in patients with cognitive disorders. Combinostics is working on a web-based cognitive test tool, cCOG. The tool is currently for research use only. Adapted from...
Combinostics will be attending the ACTRIMS virtual MS conference from September 11th-13th. We will showcase our cNeuro® cMRI application for quantitative longitudinal analysis of MRI scans. To find out more, come and talk to us at our virtual booth.